Anti-Inflammatory Effects of Adipose-Derived Mesenchymal Stem Cells and Their Exosomes in the Cortex and Striatum in a Nonalcoholic Steatohepatitis Model.

Authors

Nahid Jashirenezhad, Zahra Moayedfard, Maryam Hosseini, Zahra Jafarinezhad, Fatemeh Derisfard, Farhad Koohpeyma, Negar Azarpira, Hadi Aligholi

Published in

Current stem cell research & therapy. Sep 17, 2026. Epub Sep 17, 2026.

Abstract

Brain injury associated with Non-Alcoholic Fatty Liver Disease (NAFLD) has emerged as an important health concern, yet effective therapeutic strategies remain limited. Recently, Adipose-Derived Mesenchymal Stem Cells (AD-MSCs) and their Exosomes (AD-MSCExosomes) have attracted attention as promising therapeutic approaches. This study investigated the protective effects of AD-MSCs and their exosomes on the cortex and striatum in a mouse model of Non-Alcoholic Steatohepatitis (NASH).
Male C57BL/6 mice were fed a High-Fat Diet (HFD) for eight weeks to induce NASH. During the 6th, 7th, and 8th weeks, mice received intravenous injections of either 1×10⁶ AD-MSCs or 100 μg of exosomes. The percentage of degenerating cells in the cortex and striatum was assessed, and the gene expression levels of TNF-α, IL-1β, IL-10, and BDNF were evaluated in both brain regions.
NAFLD significantly increased the percentage of degenerating cells in the cortex and striatum. Treatment with AD-MSCs and their exosomes markedly reduced cellular degeneration in both regions. In addition, NAFLD induced overexpression of BDNF and IL-1β in the cortex, as well as BDNF and TNF-α in the striatum, while IL-10 expression in the striatum was decreased. Most therapeutic interventions effectively reversed these alterations.
The findings indicate that AD-MSCs and their exosomes may exert neuroprotective effects against NAFLD-associated brain injury, potentially through modulation of inflammatory pathways and reduction of neuronal degeneration in the cortex and striatum.
AD-MSCs and their exosomes attenuated brain tissue degeneration and modulated inflammatory cytokine expression in the cortex and striatum, suggesting their potential as therapeutic candidates for NAFLD-related neurological complications.

PMID:
42770358
Bibliographic data and abstract were imported from PubMed on 22 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.